Heart Failure Prevention Clinical Trial

Do you have Type 2 Diabetes and Heart Disease? You may be at increased risk of developing heart failure.

Consider joining a new clinical trial exploring a potential treatment to reduce your likelihood of developing heart failure.

The study aims to investigate the effectiveness of an investigational medication, baxdostrat, in combination with an already approved treatment for Type 2 Diabetes, Kidney Disease and Heart Disease called dapagliflozin, to determine if they can help prevent the chance of developing heart failure.

You may be eligible if you:

  • Are at least 40 years of age

  • Have Type 2 diabetes

  • Have heart disease, such as heart attack, stroke or poor blood flow to legs or arms

  • Have high blood pressure (hypertension)

  • Have not already been diagnosed with heart failure

There may be additional requirements that our team will discuss with you to see if you qualify.

Qualified Participants May:
  • Receive reimbursement up to $2,700 for time and travel
  • See a study doctor at no cost
  • Receive access to study medications

Participation is voluntary, and health insurance is not required.

Study Location:

This study is taking place at in Stamford, CT and Bridgeport, CT

How to Apply:

Submit your information using our form on the right side of this page. A member of our friendly team will reach out to discuss next steps and answer your questions

Heart Failure Prevention Study

Compensation

Reimbursement up to $2,700 may be available for time and travel for those who qualify. No cost to participate. Health insurance not required.

Eligible Ages

Open to people aged 40+.

Apply to Participate

Please fill out the form to see if you qualify to participate.